Abvc Biopharma (ABVC) Shares Issued (2021 - 2024)

Abvc Biopharma's (ABVC) quarterly Shares Issued came in at $258710.0 in Q3 2024, little changed on a QoQ basis from $258710.0 in Q2 2024.

Abvc Biopharma (ABVC) Shares Issued (2021 - 2024) Analysis & Trends

Abvc Biopharma (ABVC) has 3 years of Shares Issued data on file, last reported at $258710.0 in Q3 2024.

Quarterly Shares Issued changed N/A year-over-year to $258710.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $258710.0 (changed N/A YoY) and the FY2022 annual result came in at $761920.0, down 40.48% from the prior year.
Shares Issued held at $258710.0 in Q3 2024, from $258710.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $2.6 million in Q1 2024 to a low of $258710.0 in Q2 2024.
A 3-year average of $1.0 million and a median of $761920.0 in 2022 frame the typical range for Shares Issued.
The widest YoY moves for Shares Issued: up 40.48% in 2022, down 40.48% in 2022.
Tracing ABVC's Shares Issued over 3 years: stood at $1.3 million in 2021, then slumped by 40.48% to $761920.0 in 2022, then sank by 66.04% to $258710.0 in 2024.
The last three Shares Issued figures came in at $258710.0 (Q3 2024), $258710.0 (Q2 2024), and $2.6 million (Q1 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Abvc Biopharma	23.34 Mn	23.34 Mn	-	-

Download Data